Sara Ramadan, MD

Boston Medical Center - Brighton
Brighton, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• SUN-811 - Cardiovascular Safety of Romosozumab Versus Alendronate in Postmenopausal Women with Severe Osteoporosis

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• ORF43-02 - Cardiovascular Safety of Romosozumab Versus Alendronate in Postmenopausal Women with Severe Osteoporosis

  Monday, June 15, 2026
  9:35 AM - 9:40 AM CT